A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design

BACKGROUND: Neoadjuvant radiochemotherapy (RCT) is now part of the armamentarium of cancer of the lower and middle rectum. It is recommended in current clinical practice prior to surgical excision if the lesion is classified T3/T4 or N+. Histological complete response, defined by the absence of pers...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lefevre, Jérémie H, Rousseau, Alexandra, Svrcek, Magali, Parc, Yann, Simon, Tabassome, Tiret, Emmanuel
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848646/
https://ncbi.nlm.nih.gov/pubmed/24028546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-417
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky